M&T Bank
CTKB icon

M&T Bank’s Cytek Biosciences CTKB Stock Holding History

M&T Bank’s Portfolio CTKB Stock Details CTKB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$45K Buy
10,308
+51
+0.5% +$241 ﹤0.01% 1666
2025
Q4 		$51.8K Buy
+10,257
New +$47.6K ﹤0.01% 1651

Other funds holding CTKB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

M&T Bank's CTKB Position: Q1 2026 in Review

M&T Bank increased its Cytek Biosciences (CTKB) stake by 0.5% in Q1 2026, buying an estimated $241 and bringing the position to 10,308 shares worth $45K. The position accounts for ﹤0.01% of the portfolio, ranked #1666.

M&T Bank first reported a position in CTKB in Q4 2025 and has held it in 2 quarters since. The position peaked at $51.8K in Q4 2025. 165 funds tracked by Wall St. Rank hold CTKB as of Q1 2026.

  • M&T Bank held 10,308 shares of Cytek Biosciences worth $45K as of Q1 2026.
  • M&T Bank bought 51 Cytek Biosciences shares in Q1 2026, an estimated $241.
  • Cytek Biosciences made up ﹤0.01% of M&T Bank's portfolio in Q1 2026, its #1666 holding.
  • M&T Bank first reported a position in Cytek Biosciences in Q4 2025 and has held it in 2 quarters since.
  • M&T Bank's Cytek Biosciences position peaked at $51.8K in Q4 2025.
  • 165 funds tracked by Wall St. Rank held Cytek Biosciences as of Q1 2026.

Based on M&T Bank's 13F filing for Q1 2026, filed 12 May 2026.